CD20-positive B-cell Non-Hodgkin's Lymphoma
2 clinical trials · Condition
◉ Watch CD20-positive B-cell Non-Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma (NCT05805943) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2020-03-02 |
| B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma (NCT03332121) | Shanghai Pharmaceuticals Holding Co., Ltd | 2018-03-22 |
Track CD20-positive B-cell Non-Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.